Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery

The Annals of Thoracic Surgery

Volumn 59, Issue SUPPL. 1, 1995, Pages

  Svedjeholm, Rolf ^a   Hkanson, Erik ^a   Vanhanen, Ingemar ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUCOSE; INSULIN; POTASSIUM;

CARDIOPLEGIA; CONFERENCE PAPER; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART SURGERY; HUMAN; PRIORITY JOURNAL;

AMINO ACIDS; ANIMAL; CARDIAC SURGICAL PROCEDURES; GLUCOSE; HUMAN; INSULIN; MYOCARDIAL ISCHEMIA; MYOCARDIUM; POTASSIUM;

EID: 0028833913     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(94)00917-V     Document Type: Article

References (91)

1. The physiological chemistry of energy production in the heart
2. Carbohydrates and lipids
3. Alterations of myocardial amino acid metabolism in chronic ischemic heart disease
4. Myocardial glutamate and alanine exchanges related to carbohydrate metabolism in patients with normal and stenotic coronary arteries
5. Metabolic responses to hypoxia: increased production of succinate by rabbit papillary muscles
6. Augmented conversion of aspartate and glutamate to succinate during anoxia in rabbit heart
7. Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion
8. Effect of ischemia on rat myocardial function and metabolism in diabetes
9. Association of myocardial glutamate and aspartate pool and functional recovery of postischemic heart
10. Influence of free fatty acids on myocardial oxygen consumption and ischemic injury
11. Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine
12. Free fatty acids and myocardial function in perfused rat hearts
13. Uncoupling activity of long-chain fatty acids
14. The effect of free fatty acids on myocardial oxygen consumption during atrial pacing and catecholamine infusion in man
15. Reduced oxygen extraction during reperfusion: a consequence of global ischemic arrest
16. Mechanism of defective oxygen extraction following global ischemia
17. Reversal of ischemic damage with amino acid substrate enhancement during reperfusion
18. Trauma metabolism the heart. Uptake of substrates and effects of insulin early after cardiac operations
19. Decreased postoperative myocardial free fatty acid oxidation
20. Regulation of the tricarboxylic acid pool size in heart muscle
21. An assessment of anaerobic metabolism during ischemia and reperfusion in isolated guinea pig heart
22. Effects of ischemia and reperfusion on pyruvate dehydrogenase activity in isolated rat hearts
23. Dopamine and high-dose insulin infusion (glucose-insulin-potassium) after a cardiac operation: effects on myocardial metabolism
24. Metabolic response to trauma and infection
25. The effect of four different crystalloid bypass pump-priming fluids upon the metabolic response to cardiac operation
26. Trauma metabolism and the heart: studies of heart and leg amino acid flux after cardiac surgery
27. The effect of insulin on the leg and splanchnic balance of glucose and gluconeogenic substrates after cardiac surgery
28. Splanchnic glucose balance and insulin resistance in the early postoperative phase of cardiac surgery
29. Mitochondrial-cytosolic interactions in perfused rat heart Role of coupled transamination in repletion of citric acid cycle intermediates
30. Glucose and lactate balances in heart and leg after coronary surgery: influence of insulin infusion
31. Myocardial uptake of amino acids and other substrates in relation to myocardial oxygen consumption four hours after cardiac surgery
32. Myocardial uptake of substrates early after cardiac surgery. A clinical study of metabolic derangement and recovery with special reference to effects of dopamine and insulin
33. Carbohydrate and lipid metabolism in open-heart surgery
34. The effects of shivering on oxygen consumption and carbon dioxide production in patients rewarming from hypothermic cardiopulmonary bypass
35. Physiologic aspects in postoperative cardiac patients
36. Glucose-insulin-potassium in acute myocardial infarction
37. Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement
38. Effect of valvular aortic stenosis on insulin sensitivity
39. Protective role of increased myocardial glycogen stores in cardiac anoxia in the rat
40. Improved myocardial protection during cold cardioplegia by means of increased myocardial glycogen stores
41. Importance of preoperative myocardial glycogen levels in human cardiac preservation. Preliminary report
42. Glucose/insulin/potassium therapy: a reevaluation of myocardial benefits during cardiopulmonary bypass
43. Glucose and insulin supply before cardiopulmonary bypass in cardiac surgery: a double-blind study
44. Improved myocardial protection in open heart surgery by massive preoperative insulin supply
45. Prebypass glucose-insulin-potassium infusion in elective non-diabetic coronary artery surgery patients
46. High-dose insulin improves the efficacy of dopamine early after cardiac surgery a study of myocardial performance and oxygen consumption
47. Haemodynamic effects of a single large dose of insulin in open heart surgery
48. Postoperative therapy by means of acute paren-teral alimentation (APA) with high doses of insulin and glucose after open heart surgery [Author's Translation]
49. The positive inotropic action of insulin in the canine heart
50. Haemodynamic effects of high doses of insulin during acute left ventricular failure in dogs
51. Insulin as a vasodilating agent in the first hour after cardiopulmonary bypass
52. Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting
53. The metabolic significance of the malate-aspartate cycle in heart
54. Endogenous alanine glutamate aspartate and glutamine in the perfused guinea pig heart: effect of substrates and cardioactive agents
55. Protection of ischemic rabbit myocardium by glutamic acid
56. Amino acid stimulation of oxygen and substrate utilization by cardiac myocytes
57. Regulation of cardiac metabolism by amino acids in ischemia and hypoxia
58. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched amino acid formulation
59. Reduction of postischemic myocardial dysfunction by substrate repletion during reperfusion
60. Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion
61. Improved recovery of immature myocardium with l-glutamate blood cardioplegia
62. Myocardial high-energy phosphate replenishment during ischemic arrest: aerobic versus anaerobic metabolism
63. Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted
64. Studies of myocardial protection in the immature heart. V. Safety of prolonged aortic clamping with hypocalcemic glutamate/aspartate blood cardioplegia
65. Reduction of infarct size by systemic amino acid supplementation during reperfusion
66. Effect of aspartate and glutamate on experimental myocardial infarction in rats
67. Studies on prolonged acute regional ischemia. V. Metabolic support of remote myocardium during left ventricular power failure
68. Alterations in myocardial uptake of glutamate release of alanine after propranolol nifedipine and glyceryl trinitrate in coronary artery disease
69. Effects of glutamate on exercise tolerance and circulating substrate levels in stable angina pectoris
70. Antiischemic and metabolic effects of glutamate during pacing in patients with stable angina pectoris secondary to either coronary artery disease or syndrome X
71. Myocardial protection during cardiac operations. Decreased morbidity and lower cost with blood cardioplegia and coro-nary sinus perfusion
72. Protective effect of glutamic acid on cardiac function and metabolism during cardioplegia and reperfusion
73. Warm glutamate/aspartate-enriched blood cardioplegic solution for perioperative sudden death
74. Early recovery of regional wall motion in patients following surgical revascularization after eight hours of acute coronary occlusion
75. Early recovery of regional wall motion in patients following surgical revascularization after eight hours of acute coronary occlusion
76. Warm induction of cardioplegia with glutamate-enriched blood in coronary artery patients with cardiogenic shock who are dependent on inotropic drugs and intra-aortic balloon sup-port
77. Glutamate-blood cardioplegia improves ATP preservation in human myocardium
78. Cardiac metabolism and performance during l-glutamic acid infusion in postoperative cardiac failure
79. Glutamate infusion stimulates oxidative metabolism of the heart early after coronary surgery [Abstract]
80. Preferential uptake of lactate by the normal myocardium in dog
81. Improving myocardial metabolic and functional recovery after cardiac arrest
82. 1-blockade early after coronary surgery. A hemodynamic, metabolic and electrophysiologic study with special reference to effects of metoprolol
83. Mitochondrial myocardial performance. Response to ischemia and reperfusion
84. Mechanism of myocardial stunning
85. Studies of controlled reperfusion after ischemia. Immediate functional recovery after six hours of regional ischemia by careful control of conditions of reperfusion and composition of reperfusate
86. Cardiopulmonary dysfunction produced by reoxygenation of immature hypox-emic animals supported by cardiopulmonary bypass Prevention by intravenous metabolic pretreatment
87. Coronary hemodynamics myocardial metabolism of lactate, free fatty acids, glucose and ketones in patients with septic shock
88. Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations
89. Detrimental effects of premature use of inotropic drugs to discontinue cardiopulmonary bypass
90. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine
91. Factors influencing infarct size following experimental coronary artery occlusions